Charles M. Baum - 09 Aug 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
Interim CEO, Director
Signature
/s/ John Moriarty, Attorney-in-Fact
Issuer symbol
MRTX
Transactions as of
09 Aug 2023
Transactions value $
$1,999,998
Form type
4
Filing time
10 Aug 2023, 16:24:44 UTC
Previous filing
28 Jun 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $2M +54.1K +31.21% $37.00 227K 09 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the one year anniversary of the grant date.